Patents by Inventor Maryse Brait

Maryse Brait has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding a heme binding protein polypeptide
    Patent number: 7842795
    Abstract: The present invention relates to methods, reagents and kits for detecting of formyl peptide receptor like-2 (FPRL2) polypeptide activity in a sample and identifying agents which modulate polypeptide activity. It further relates to antibodies raised against FPRL2. It further relates to substances for preventing, treating and/or alleviating diseases or disorders characterized by dysregulation of FPRL2 polypeptide signalling.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: November 30, 2010
    Assignee: Euroscreen S.A.
    Inventors: Isabelle Migeotte, Marc Parmentier, David Communi, Maryse Brait
  • Ligand for G-protein coupled receptor FPRL2
    Patent number: 7659251
    Abstract: The present invention relates to methods, reagents and kits for detecting of formyl peptide receptor like-2 (FPRL2) polypeptide activity in a sample and identifying agents which modulate polypeptide activity. It further relates to antibodies raised against FPRL2. It further relates to substances for preventing, treating and/or alleviating diseases or disorders characterized by dysregulation of FPRL2 polypeptide signalling.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: February 9, 2010
    Inventors: Isabelle Migeotte, Marc Parmentier, David Communi, Maryse Brait
  • Nucleic acids encoding a heme binding protein polypeptide
    Publication number: 20100009406
    Abstract: The present invention relates to methods, reagents and kits for detecting of formyl peptide receptor like-2 (FPRL2) polypeptide activity in a sample and identifying agents which modulate polypeptide activity. It further relates to antibodies raised against FPRL2. It further relates to substances for preventing, treating and/or alleviating diseases or disorders characterized by dysregulation of FPRL2 polypeptide signalling.
    Type: Application
    Filed: March 13, 2008
    Publication date: January 14, 2010
    Inventors: Isabelle Migeotte, Marc Parmentier, David Communi, Maryse Brait
  • Ligand for G-protein coupled receptor FPRL2 and uses thereof
    Patent number: 7582416
    Abstract: The present invention relates to methods, reagents and kits for detecting of formyl peptide receptor like-2 (FPRL2) polypeptide activity in a sample and identifying agents which modulate polypeptide activity. It further relates to antibodies raised against FPRL2. It further relates to substances for preventing, treating and/or alleviating diseases or disorders characterized by dysregulation of FPRL2 polypeptide signalling.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: September 1, 2009
    Inventors: Isabelle Migeotte, Marc Parmentier, David Communi, Maryse Brait
  • Ligand for G-protein coupled receptor FPRL2 and uses thereof
    Publication number: 20090053739
    Abstract: The present invention relates to methods, reagents and kits for detecting of formyl peptide receptor like-2 (FPRL2) polypeptide activity in a sample and identifying agents which modulate polypeptide activity. It further relates to antibodies raised against FPRL2. It further relates to substances for preventing, treating and/or alleviating diseases or disorders characterized by dysregulation of FPRL2 polypeptide signalling.
    Type: Application
    Filed: March 13, 2008
    Publication date: February 26, 2009
    Inventors: Isabelle Migeotte, Marc Parmentier, David Communi, Maryse Brait
  • Ligand for G-protein coupled receptor FPRL2 and uses thereof
    Publication number: 20060078559
    Abstract: The present invention relates to methods, reagents and kits for detecting of formyl peptide receptor like-2 (FPRL2) polypeptide activity in a sample and identifying agents which modulate polypeptide activity. It further relates to antibodies raised against FPRL2. It further relates to substances for preventing, treating and/or alleviating diseases or disorders characterized by dysregulation of FPRL2 polypeptide signalling.
    Type: Application
    Filed: May 13, 2005
    Publication date: April 13, 2006
    Inventors: Isabelle Migeotte, Marc Parmentier, David Communi, Maryse Brait